Skip to main content
. Author manuscript; available in PMC: 2014 May 27.
Published in final edited form as: Oncologist. 2008 May;13(5):494–502. doi: 10.1634/theoncologist.2007-0200

Table 3.

Multivariate analysis for predictors of i.v. bisphosphonate use

Odds ratio 95% confidence interval
Age
 65–69 1.0 (ref)
 70–74 0.88 0.78–1.01
 75–79 0.81 0.70–0.93
 80+ 0.49 0.42–0.57

Race/ethnicity
 White 1.00 (ref)
 Black 0.78 0.62–0.98
 Hispanic 0.81 0.61–1.06
 Other 0.78 0.58–1.05

Marital status
 Married 1.00 (ref)
 Unmarried 1.00 0.90–1.11
 Unknown 0.94 0.68–1.29

Poverty (from least to most)
 1st quartile 1.00
 2nd quartile 0.91 0.78–1.05
 3rd quartile 0.95 0.80–1.12
 4th quartile 0.96 0.78–1.17
 Unknown 1.74 0.98–3.10

Education (from most to least)
 1st quartile 1.00 (ref)
 2nd quartile 0.91 0.78–1.06
 3rd quartile 1.13 0.96–1.33
 4th quartile 0.86 0.71–1.05

Stage at diagnosis
 In situ 1.00 (ref)
 Localized 2.89 2.17–3.85
 Regional 11.04 8.30–14.69
 Distant 114.83 85.87–153.55
 Unknown 12.65 7.77–20.59

Calendar year
 1995 0.01 0.00–0.46
 1996 0.14 0.08–0.26
 1997 0.49 0.38–0.62
 1998 1.0 (ref)
 1999 1.52 1.32–1.75
 2000 2.22 1.90–2.60
 2001 2.55 2.17–3.00
 2002 2.21 1.87–2.61
 2003 4.46 3.79–5.24
 2004 4.94 4.19–5.82